Experimental study on the possibility of treatment of some hemorrhagic fevers

Journal of Biotechnology

Volumn 83, Issue 1-2, 2000, Pages 67-76

  Ignatyev, George ^a   Steinkasserer, Alexander ^b   Streltsova, Marina ^a   Atrasheuskaya, Alena ^a   Agafonov, Alexander ^a   Lubitz, Werner ^b  

^a STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

IL 1RA; Inflammatory cytokines; Lassa virus; Marburg virus

Indexed keywords

BLOOD; LIVING SYSTEMS STUDIES; VIRUSES;

INFECTIONS;

DISEASES;

INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC FEVER; LASSA FEVER; LASSA VIRUS; MALE; MARBURG VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS HEMORRHAGIC FEVER;

ANIMALIA; CAVIA; LAKE VICTORIA MARBURGVIRUS; LASSA VIRUS; LASSA VIRUS (STRAIN JOSIAH); RNA VIRUSES;

EID: 0034730591     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1656(00)00300-X     Document Type: Article

References (38)

1. Agafonov, A.P., Streltsova, M.A., Ignatyev, G.M. et al., 1991. The method of preparation of concentrates of haemorrhagic fever viruses possessing immunogenic and protective activity. Patent of the Russian Federation RU 2029561 C1.
2. Aronson J.F., Herzog N.K., Jerrells T.R. Tumor necrosis factor and the pathogenesis of Pichinde virus infection in guinea pigs. Am. J. Trop. Med. Hyg. 52:1995;262-269.
3. Bagby G.J., Plessala K.J., Wilson L.A., Thompson J.J., Nelson S. Divergent efficacy of antibody to tumor necrosis factor-a in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163:1991;83-88.
4. Bevilacqua M.P., Pober J.S., Majeau G.R., Fiers W., Cotran R.S., Gimbrone M.A. Jr Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc. Natl. Acad. Sci. USA. 83:1986;4533-4537.
5. Blaheta R.A., Scholz M., Hailer N.P., Bereiter-Hahn J., Encke A., Markus B.H. Adhesion and penetration properties of human lymphocytes acting on allogenic vascular endothelial cells. Immunology. 81:1994;538-545.
6. Calandra T., Baumgartner J.-D., Grau G.E. et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-a, and interferon-g in the serum of patients with septic shock. J. Infect. Dis. 161:1990;982-987.
7. Chaplin D.D., Hogquist K.A. Interactions between TNF and interleukin-1. Beuter B. Tumor Necrosis Factors: the Molecules and Their Emerging Role in Medicine. 1992;197-220 Raven Press, New York.
8. Cummins D. Arenaviral haemorrhagic fevers. Blood Rev. 5:1991;129-137.
9. Dayer J-M, Burger D Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur. Cytokine Netw. 5:1994;563-571.
10. Demby A.H., Chamberlain J., Brown D.W.G., Clegg C.S. Early diagnosis of Lassa fever by reverse transcription-PCR. J. Clin. Microbiol. 32:1994;2898-2903.
11. Dinarello C.A. The biological properties of interleukin-1. Eur. Cytokine Netw. 5:1994;517-531.
12. Feldmann H., Bugany H., Mahner F., Klenk H.-D., Drenckhahn D., Schnittler H.-J. Filovirus-induced endothelial leakage triggered by infected macrophages. J. Virol. 70:1996;2208-2214.
13. Fisher C.J. Jr, Dhainaut J.-F.A, Opal S.M. et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. J. Am. Med. Assoc. 271:1994;1836-1843.
14. Fisher C.J. Jr, Agosti J.M., Opal S.M. et al. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. New Engl. J. Med. 334:1996;1697-1702.
15. Fisher-Hoch S.P., Platt G.S., Neild G.H. et al. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J. Infect. Dis. 152:1985;887-894.
16. Frolov A.S., Pika I.S., Eroshkin A.M. ProMSED: protein multiple sequence editor for Windows3.11/95. CABIOS. 13:1997;243-248.
17. Heller M.V., Saavedra M.C., Falcoff R., Maiztegui J.I., Molinas F.C. Increase tumor necrosis factor-α levels in Argentine hemorrhagic fever. Infect. Dis. 166:1992;1203-1204.
18. Ignatyev G.M., Agafonov A.P., Streltsova M.A., Spirin G.A., Mainagarova G.I., Chernii N.B. Comparative analysis of some immunological parametrs of inactivated Marburg viruses in guinea pigs. Vopr. Virusol. 36:1991;421-423.
19. Ignatyev G.M, Streltsova M.A, Agafonov A.P. et al. Immunologic characteristics of guinea pigs with Marburg hemorrhagic fever. Vopr. Virusol. 39:1994;160-171. (in Russian).
20. Ignatyev, G.M., Kaliberov, S.A., Godneva, A.T. et al., 1995. Immunity parameters in mice of different lines infected with Machupo or Lassa viruses. Immunobiology of Viral Infections, Proc. 3rd Congress European Society of Veterinary Virologists, pp. 250-253.
21. Ignatyev G.M., Agafonov A.P., Streltsova M.A., Kashentseva E.A. Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys. J. Biotechnol. 44:1996;111-118.
22. Ignatyev, G.M., Streltsova, M.A., Kashentseva, E.A., Patruschev, N.A., Ginko, S.I., Agafonov, A.P., 1996. Immunity indices in the personnel involved in hemorrhagic virus. In: Berg D.A. (Ed), Proc. of the 1996 ERDC Scientific Conference on Chemical and Biological Defense Reserch, 19-22 November 1996, pp. 323-330.
23. Ignatyev G.M., Streltsova M.A., Agafonov A.P., Kashentseva E.A., Prozorovsky N.S. Experimental study of therapy of Marburg hemorrhagic fever with desferal, ribavirin and homologous interferon. Vopr. Virusol. 41:1996;206-209.
24. Ignatyev G.M., Streltsova M.A., Kashentseva E.A. Induction of the mediators of the immunity in the human mononuclear cells culture by Marburg virus. Vopr. Virusol. 43:1998;169-173.
25. Isogal E., Isogal H., Kimura K. et al. Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Infect. Immun. 66:1998;197-202.
26. Jahrling P.B., Smith S., Hesse R.A., Rhoderick J.B. Pathogenesis of Lassa Infection in guinea pigs. Infect. Immun. 37:1982;771-778.
27. Lampugnani M.G., Resnati M., Raiteri M. et al. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J. Cell. Biol. 118:1992;1511-1522.
28. Lennard A.C. Interleukin-1 receptor antagonist. Crit. Rev. Immunol. 15:1995;77-105.
29. Martinez E., Guzman M.G., Valdes M., Soler M., Kourni G. Dengue fever and hemorrhagic dengue in infants with primary infection. Rev. Cuba. Med. Trop. 45:1993;97-101.
30. Netea M.G., Blok W.L., Kullberg B.-J. et al. Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J. Infect. Dis. 171:1994;393-399.
31. Peters, C.J., Johnson, E.D., McKee, K.T., Jr., 1991. Filoviruses and management of viral hemorrhagic fever. In: Belshe (Ed.), RB Textbook of Human Virology. Mosby Year Book, pp. 699-712.
32. Poljkov I.V., Sokolova N.S. Practice of Medical Statistics. 1975;Medicina Press, Leningrad.
33. Pruitt J.H., Welborn M.B., Edwards P.D. et al. Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood. 87:1996;3282-3288.
34. Silva A.T, Bayston K.F., Cohen J. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-a in experimental gram-negative shock. J. Infect. Dis. 162:1990;421-427.
35. Steinkasserer A., Solari R., Mott H.R. et al. Human interleukin-1 receptor antagonist. High yield expression in E. coli and examination of cysteine residues. FEBS. 310:1992;63-65.
36. Tracey K.J., Fong Y, Hesse D.G. et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 330:1987;662-664.
37. Villinger F., Rollin P.E., Brar S.S. et al. Markedly elevated levels of interferon (IFN)-ν, IFN-α, Interleukin (IL)-2, IL-10, and tumor necrosis factor-α associated with fatal Ebola virus infection. J. Infect. Dis. 179(Suppl. 1):1999;188-191.
38. Wertheimer S.J., Myers C.L., Wallace R.W., Parks T.P. Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-a and phorbol myristate acetate. J. Biol. Chem. 267:1992;12030-12035.